Indication
Enthesitis-related juvenile idiopathic arthritis
Enthesitis-related juvenile idiopathic arthritis is a chronic inflammatory disorder and specific subtype of juvenile idiopathic arthritis that primarily impacts children and adolescents, most frequently presenting in older boys. Read more about Enthesitis-related juvenile idiopathic arthritis
16 drugs 2 manufacturers
Drugs that treat it
Common Enthesitis-related juvenile idiopathic arthritis therapies.
COSENTYX SENSOREADY (2 PENS) (secukinumab)
COSENTYX SENSOREADY PEN (secukinumab)
COSENTYX SYRINGE (secukinumab)
COSENTYX UNOREADY PEN (secukinumab)
COSENTYX PEN (secukinumab)
COSENTYX PEN (secukinumab)
COSENTYX PEN (2 PENS) (secukinumab)
COSENTYX SENSOREADY (2 PENS) (secukinumab)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonEnthesitis-related juvenile idiopathic arthritis is a chronic inflammatory disorder and specific subtype of juvenile idiopathic arthritis that primarily impacts children and adolescents, most frequently presenting in older boys.
It predominantly targets the musculoskeletal system, characterized by the co-occurrence of synovitis—typically presenting as asymmetric arthritis of the lower extremity joints—and enthesitis, which is localized inflammation and tenderness where tendons, ligaments, or joint capsules insert into bone.
Pathophysiologically categorized under the juvenile spondyloarthritis spectrum, it is strongly associated with the HLA-B27 genetic marker and frequently carries potential progression to axial involvement, including sacroiliitis and spinal inflammation, as well as extra-articular manifestations such as acute anterior uveitis.
- rarediseases.org
Enthesitis-related juvenile idiopathic arthritis is a chronic inflammatory disorder and specific subtype of juvenile idiopathic arthritis that primarily impacts children and adolescents, most frequently presenting in older boys It predominantly targets the musculoskeletal system, characterized by the co-occurrence of synovitis—typically presenting as asymmetric arthritis of the lower extremity joints—and enthesitis, which is localized inflammation and tenderness where tendons, ligaments, or join...
- aap.org
Enthesitis-related juvenile idiopathic arthritis is a chronic inflammatory disorder and specific subtype of juvenile idiopathic arthritis that primarily impacts children and adolescents, most frequently presenting in older boys It predominantly targets the musculoskeletal system, characterized by the co-occurrence of synovitis—typically presenting as asymmetric arthritis of the lower extremity joints—and enthesitis, which is localized inflammation and tenderness where tendons, ligaments, or join...
- jrd.or.kr
It predominantly targets the musculoskeletal system, characterized by the co-occurrence of synovitis—typically presenting as asymmetric arthritis of the lower extremity joints—and enthesitis, which is localized inflammation and tenderness where tendons, ligaments, or joint capsules insert into bone Pathophysiologically categorized under the juvenile spondyloarthritis spectrum, it is strongly associated with the HLA-B27 genetic marker and frequently carries potential progression to axial involvem...
- orpha.net
Pathophysiologically categorized under the juvenile spondyloarthritis spectrum, it is strongly associated with the HLA-B27 genetic marker and frequently carries potential progression to axial involvement, including sacroiliitis and spinal inflammation, as well as extra-articular manifestations such as acute anterior uveitis
Personalize your experience
Follow Enthesitis-related juvenile idiopathic arthritis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.